Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma

Journal of Obstetrics and Gynaecology

Volumn 25, Issue 5, 2005, Pages 419-421

  Eskandar, O S ^a,b   Eckford, S D ^a   Whittaker, K W ^a  

^a NORTH DEVON DISTRICT HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DARIFENACIN; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPANTHELINE BROMIDE; PROPIVERINE; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; TROSPIUM CHLORIDE;

AQUEOUS HUMOR; AQUEOUS HUMOR FLOW; CLOSED ANGLE GLAUCOMA; DISEASE CLASSIFICATION; DRUG SAFETY; ENURESIS; GLAUCOMA; HUMAN; MYDRIASIS; OPEN ANGLE GLAUCOMA; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADULT; CHOLINERGIC ANTAGONISTS; FEMALE; GLAUCOMA; HUMANS; MIDDLE AGED; URINARY INCONTINENCE;

EID: 31944446146     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610500160675     Document Type: Review

References (11)

1. Abrams P. 2002. Physiology and treatment of OAB: A urologist's view. Trends in Urology Gynaecology & Sexual Health Supplement pp 3-4.
2. Ates H, Kayikcioglu O, Andac K. 1999. Bilateral angle closure glaucoma following general anaesthesia. International Ophthalmology 23:129-130.
3. Kadoi C, Hayasaka S, Tsukamoto E, Matsumoto M, Hayasaka Y, Nagaki Y. 2000. Bilateral angle closure glaucoma and visual loss precipitated by antidepressant and antianxiety agents in a patient with depression. Ophthalmologica 214:360-361.
4. Kanski J. 1994. Clinical ophthalmology. A systematic approach. 4th ed. London: Butterworth Heinemann. p 186.
5. Luesley D, Baker P (Eds). 2004. Urinary incontinence. In: Obstetrics and Gynaecology. London: Arnold. p 642.
6. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. 2001. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU International 87:760-766.
7. Nilvebrant L. 2000. The mechanism of action of tolterodine. Review of Contemporary Pharmacotherapy 1:13-27.
8. Ouslander JG, Blaustein J, Connor A, Orzeck S, Yong CL. 1988. Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. Journal of Urology 140:47-50.
9. Ritch R, Krupin T, Henry C, Kurata F. 1994. Oral imipramine and acute angle closure glaucoma. Archives of Ophthalmology 112:67-68.
10. Sung V, Corridan P. 1998. Acute angle closure glaucoma as a side effect of oxybutynin. BJU International 81:634-635.
11. Tripathi RC, Tripathi BJ, Haggerty C. 2003. Drug-induced glaucomas: mechanisms and management. Drug Safety 26:749-767.